AI-POWERED RESEARCH INTELLIGENCE

Finding therapies hidden in 1,516 Parkinson’s papers.

Neurocompute scores biomedical literature, surfaces overlooked patterns, and turns Parkinson’s research into a living discovery terminal.

1,516Papers indexed
984Papers AI scored
998Ranked papers
0.7%Coverage
LIVE RESEARCH INTELLIGENCE
↑ Narrative velocity rising ↑ New papers ingested ↑ Cross-paper convergence detected ↑ AI score dials updating ↑ Research blind spots surfacing
TOP SIGNALS TODAY

Ranked discovery teasers

View all discoveries →
RESEARCH TERMINAL

All ranked Parkinson’s papers

1516 results
E
Why does FND mainly affect women? A consideration of gender imbalance in neuropsychiatric disease.
PMID 41969052 Published: 2026-04-13 Ingested: 2026-04-28 08:58 PM Psychological medicine
AI7.0
Base23.4
Rank22.9
AI Summary

Narrative review analyzing the roughly 3:1 female predominance in functional neurological disorder by synthesizing biological (notably sex hormones), psychological (trauma, dissociation), and social (gender norms, socioeconomic) contributors and diagnostic biases.

Why It Matters

Limited direct value for Parkinson's therapeutic discovery, but the paper highlights sex/gender, hormonal, and psychosocial factors that are important to consider in neurodegeneration research, trial design, and understanding comorbid neuropsychiatric presentations.

E
Hypothermia Associated With Impaired Consciousness in an Older Woman With Parkinson's Disease: A Case Report.
PMID 41909339 Published: 2026-02-01 Ingested: 2026-04-28 08:58 PM Cureus
AI18.5
Base23.2
Rank22.7
AI Summary

A single-case report of an older woman with Parkinson's disease who developed unexplained hypothermia and altered consciousness that resolved with supportive rewarming and did not recur over two years.

Why It Matters

Alerts clinicians to a rare, reversible thermoregulatory/autonomic complication of PD but provides minimal mechanistic or therapeutic information useful for Parkinson's drug discovery.

E
Neuroinflammation plays a crucial role in the pathogenesis of Parkinson's disease: a systematic review and meta-analysis of clinical and biomarker evidence.
PMID 41922829 Published: 2026-04-02 Ingested: 2026-04-28 08:58 PM Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
AI58.0
Base20.5
Rank21.9
AI Summary

This systematic review and meta-analysis synthesizes clinical and biomarker evidence indicating that neuroinflammation is a significant contributor to Parkinson's disease pathogenesis.

Why It Matters

By aggregating human clinical and biomarker data, it helps prioritize inflammatory pathways and measurable biomarkers that could be targeted or used for patient stratification in PD therapeutic development.

E
The Deep Learning Revolution in Neuroimaging: Insights from a Bibliometric Analysis (2014-2024).
PMID 41894064 Published: 2026-03-27 Ingested: 2026-04-28 08:58 PM Neuroinformatics
AI24.0
Base22.1
Rank21.8
AI Summary

A bibliometric analysis of 12,564 papers (2014–2024) mapping the rapid growth, key countries/institutions/sources, and dominant themes (deep learning, MRI) including applications to diagnosis of Parkinson's, Alzheimer's, and MCI.

Why It Matters

Helps researchers navigate the neuroimaging–AI landscape to find datasets, methods, and collaborators for imaging-based biomarkers or diagnostic ML for Parkinson's, but offers little mechanistic or therapeutic actionable insight.

E
Place of death in Parkinson's disease: A systematic review and meta-analysis of associated factors.
PMID 41995464 Published: 2026-04-17 Ingested: 2026-04-28 08:58 PM Journal of Parkinson's disease
AI18.0
Base22.1
Rank21.8
AI Summary

Systematic review and meta-analysis of 33 studies (over 1.2 million people) identifying factors associated with hospital vs non‑hospital death in Parkinson's disease—hospital death was more likely in men, married people, those under 85, with suggestive higher odds in non‑white groups and lower odds…

Why It Matters

Useful for informing end‑of‑life care planning, service provision, and targeted palliative interventions but of limited direct value for Parkinson's therapeutic discovery because it lacks mechanistic, biomarker, or intervention development insights.

E
Mixture effects of dietary fatty acids on Parkinson's disease: A weighted quantile sum analysis.
PMID 41965949 Published: 2026-04-09 Ingested: 2026-04-28 08:58 PM Parkinsonism & related disorders
AI35.0
Base21.8
Rank21.5
AI Summary

Cross-sectional analysis of NHANES data (1999–2018) found that higher intake of monounsaturated and polyunsaturated fatty acids—especially docosahexaenoic acid (DHA, C22:6)—was associated with lower odds of prevalent Parkinson's disease, while several medium-chain saturated fatty acids (C6:0–C14:0)…

Why It Matters

The study highlights dietary fatty acid composition, particularly DHA, as a potentially modifiable factor and prioritizes specific lipids for mechanistic, prospective, or interventional PD research, though causality remains unproven due to the cross-sectional design.

E
Anti-fibrotic effect of Spirulina maxima-derived extracellular vesicles: possible role of PARK7 and HSP70 chaperones.
PMID 41988013 Published: 2026-01-01 Ingested: 2026-04-28 08:58 PM Frontiers in bioengineering and biotechnology
AI28.0
Base21.8
Rank21.5
AI Summary

Spirulina maxima-derived small extracellular vesicles containing PARK7 (DJ-1) and HSP70 reduce TGF-β/PDGF-driven mesothelial/fibroblast activation and ameliorate peritoneal fibrosis in cell assays and a mouse model.

Why It Matters

While the study is peripheral and not in a neurodegeneration model, detection of PD-linked chaperones (PARK7, HSP70) in bioactive EVs raises a plausible, but unproven, avenue for EV-mediated delivery of neuroprotective factors or modulation of proteostasis relevant to Parkinson's disease, meriting…

E
FXTAS and the Spectrum of FMR1 Premutation-Associated Phenotypes in Latin America: A Scoping Review.
PMID 41937418 Published: 2026-04-05 Ingested: 2026-04-28 08:58 PM Movement disorders clinical practice
AI20.0
Base21.8
Rank21.5
AI Summary

Scoping review of 25 studies (5,531 participants) documenting 38 FXTAS cases and 386 FMR1 premutation carriers in Latin America, summarizing clinical, neuroimaging, and diagnostic features and emphasizing underdiagnosis and the need for improved genetic testing and prospective studies.

Why It Matters

Low direct value for Parkinson's therapeutic discovery—although some premutation carriers exhibit parkinsonism, the review is descriptive and regional with no mechanistic insights, biomarkers, or intervention targets that would readily inform PD drug development.

E
Clinical Outcome Assessments for Functional Performance in Spastic Paresis: Systematic Review, Critique, and Recommendations.
PMID 41909919 Published: 2026-03-30 Ingested: 2026-04-28 08:58 PM Movement disorders : official journal of the Movement Disorder Society
AI18.0
Base21.8
Rank21.5
AI Summary

Systematic review assessing clinimetric properties of 71 clinical outcome assessments for functional performance in spastic paresis, recommending specific lower-limb gait tests (10‑m walk variants, 2‑ or 6‑minute walk, Wisconsin Gait Scale) and rating two upper‑limb scales as 'recommended with…

Why It Matters

Offers validated functional outcome measures that could inform endpoint selection in movement-disorder trials (including gait/fatigue assessments relevant to Parkinson's studies), but provides little direct mechanistic or therapeutic insight for PD drug discovery.

E
DNAJC6 Parkinson's disease: Endolysosomal dysfunction and emerging roles for oligodendrocytes.
PMID 41935042 Published: 2026-04-04 Ingested: 2026-04-28 08:58 PM NPJ Parkinson's disease
AI62.0
Base21.4
Rank21.2
AI Summary

This review synthesizes genetic and experimental evidence that loss-of-function variants in DNAJC6 (auxilin) impair clathrin-mediated endocytosis, endolysosomal trafficking, autophagy, and lipid homeostasis, leading to dopaminergic neuron loss and implicating oligodendrocytes in PD.

Why It Matters

By connecting a Mendelian PD gene to endolysosomal/autophagy dysfunction and glial contributions, the paper identifies mechanistic pathways that are actionable for therapeutic targeting, biomarker development, and gene-based strategies.

E
Therapeutic potential of vagus nerve stimulation in neurodegenerative diseases: research progress and mechanisms.
PMID 41948329 Published: 2026-01-01 Ingested: 2026-04-28 08:58 PM Frontiers in immunology
AI40.0
Base21.4
Rank21.2
AI Summary

This broad review summarizes evidence that vagus nerve stimulation (VNS) can provide neuromodulatory, anti-inflammatory, and neuroprotective effects across neurodegenerative diseases including Parkinson's, and discusses its mechanisms and clinical applications.

Why It Matters

VNS targets the gut–brain axis and inflammation—mechanisms relevant to PD that offer a minimally invasive, translational therapeutic approach—but the paper is a high-level review with limited PD-specific, actionable targets or experimental data.

E
Urogenital dysfunction in neurological diseases.
PMID 41927939 Published: 2026-04-01 Ingested: 2026-04-28 08:58 PM Nature reviews. Neurology
AI22.0
Base21.4
Rank21.2
AI Summary

A clinical review of lower urinary tract and sexual dysfunction across neurological diseases that summarizes anatomy, pathophysiology, and management approaches and includes Parkinson disease among other disorders but focuses on clinical presentation and symptomatic treatment rather than molecular…

Why It Matters

Useful for improving symptomatic care, patient stratification, and awareness of autonomic dysfunction as a clinical feature in PD, but offers limited actionable insight for discovery of disease-modifying Parkinson's therapeutics.

E
Fusion of Supervised Feature Selection and Unsupervised Clustering for Multinuclei Classification of MER Signals in DBS for Parkinson's Disease.
PMID 41894203 Published: 2026-03-27 Ingested: 2026-04-28 08:58 PM IEEE transactions on neural networks and learning systems
AI50.0
Base20.6
Rank20.5
AI Summary

Introduces a hybrid pipeline combining random-forest feature selection with fuzzy c-means clustering and selective manual review to classify MER signals into zona incerta, STN, and substantia nigra with ~92.7% accuracy while reducing manual labeling to ~10%.

Why It Matters

By enabling fast, scalable, and accurate intraoperative identification of DBS target nuclei, this method can improve surgical targeting and efficiency—potentially enhancing clinical outcomes and facilitating wider deployment of DBS—though it does not directly inform molecular mechanisms or novel…

E
Structural Volumetric Alterations in Parkinson's Disease With Mild Cognitive Impairment.
PMID 42043968 Published: 2026-05-01 Ingested: 2026-04-28 08:58 PM Brain and behavior
AI38.0
Base20.6
Rank20.5
AI Summary

Meta-analysis shows PD-MCI patients have significant atrophy in hippocampus, thalamus, putamen, amygdala and right-lateralized globus pallidus compared with cognitively normal PD, while caudate volumes are preserved.

Why It Matters

Identifies a reproducible subcortical imaging signature that could serve as a biomarker for early cognitive decline and trial enrichment in PD, but offers limited direct mechanistic or therapeutic leads for drug discovery.

E
Clinicopathological features of primary tauopathies: a brain bank series.
PMID 41982423 Published: 2026-01-01 Ingested: 2026-04-28 08:58 PM Frontiers in neurology
AI25.0
Base20.6
Rank20.5
AI Summary

Retrospective Neurological Foundation Human Brain Bank series detailing clinicopathological heterogeneity of primary tauopathies (PSP, CBD, PART, AGD, genetic FTD), low clinicopathologic concordance, and availability of fixed/frozen tissue and clinical data.

Why It Matters

Offers a valuable, well-characterized tissue and clinical dataset that can aid biomarker development and patient stratification for atypical parkinsonian syndromes, but provides limited direct mechanistic or therapeutic leads for classical alpha-synuclein Parkinson's disease.

E
Differentiating Neurologic Disorders from Spinal Conditions: Evidenced-Based History and Physical Examination Clues for the Orthopedic Clinic.
PMID 42009215 Published: 2026-04-18 Ingested: 2026-04-28 08:58 PM The American journal of medicine
AI18.5
Base20.6
Rank20.5
AI Summary

A narrative review for spine clinicians describing clinical clues and diagnostic tools to distinguish neurologic disorders (including Parkinson's disease) from degenerative spinal conditions to avoid misdiagnosis and unnecessary surgery.

Why It Matters

While it offers important clinical guidance for diagnosis and referral, the paper provides minimal mechanistic or therapeutic insight for Parkinson's drug discovery, so its direct value to PD therapeutics is limited but relevant for clinical pathway optimization.

E
Plasma pTau217 as a Prognostic, Monitoring, and Risk-Stratification Biomarker of Clinical Progression in Lewy Body Disease.
PMID 41929322 Published: 2026-03-27 Ingested: 2026-04-28 08:58 PM medRxiv : the preprint server for health sciences
AI65.0
Base21.6
Rank19.9
AI Summary

This study shows plasma pTau217 predicts accelerated cognitive and functional decline and a three-fold higher risk of progression to MCI/dementia in Lewy body disease, supporting its use as a prognostic and monitoring biomarker.

Why It Matters

A blood-based tau measure that identifies Alzheimer co-pathology in LBD enables better patient stratification and longitudinal monitoring for clinical trials and practice, improving chances to test and target therapies in biologically defined subgroups even though it does not itself propose a…

E
Enhancing 7T MRI for deep brain stimulation with deep-learning based image reconstruction and dynamic parallel transmission.
PMID 41962172 Published: 2026-04-04 Ingested: 2026-04-28 08:58 PM NeuroImage. Clinical
AI55.0
Base21.6
Rank19.9
AI Summary

The study demonstrates that deep-learning image reconstruction combined with dynamic parallel transmission at 7T substantially shortens scan time while improving image quality, motion robustness, and delineation of DBS targets (STN, GPi, DRT) in patients.

Why It Matters

Enhanced high-field imaging that yields clearer, faster, and safer visualization of subcortical targets has direct translational value for Parkinson's DBS planning and may improve surgical accuracy and outcomes, though it does not introduce new disease-modifying biology.

E
Resting-State EEG Features of Cognitive Fluctuations Across the Lewy Body Disease Spectrum.
PMID 41960336 Published: 2026-03-31 Ingested: 2026-04-28 08:58 PM Research square
AI32.0
Base21.6
Rank19.9
AI Summary

Resting-state EEG measures—lower dominant frequency, reduced alpha prevalence (DFP-alpha), and lower individual alpha peak frequency—distinguish Lewy body disease patients with cognitive fluctuations from those without, with anterior DFP-alpha yielding an AUC ≈0.85.

Why It Matters

This identifies a noninvasive, readily obtainable biomarker for detecting and stratifying cognitive fluctuations in Lewy body disease, aiding diagnosis and clinical trial enrichment, though it offers limited direct mechanistic or therapeutic targets.

E
Effects of physical exercise on cognitive impairment in patients with Alzheimer's disease, Parkinson's disease or mild cognitive impairment: a systematic review and meta-analysis.
PMID 42014980 Published: 2026-04-22 Ingested: 2026-04-28 08:58 PM European review of aging and physical activity : official journal of the European Group for Research into Elderly and Physical Activity
AI30.0
Base18.0
Rank19.8
AI Summary

A broad systematic review and meta-analysis assessing the effects of physical exercise on cognitive impairment across Alzheimer's disease, Parkinson's disease, and mild cognitive impairment, but with no abstract provided and limited disease-specific mechanistic detail.

Why It Matters

Offers clinical-level support for exercise as a non-pharmacological, potentially neuroprotective intervention relevant to PD symptoms and cognitive decline, but it provides limited actionable molecular targets or therapeutic-discovery insights.

Previous
Page 41 of 76
Next
Neurocompute Parkinson’s Narrative Velocity Infographic
NEUROCOMPUTE VISUAL SYSTEM

Open the Narrative Velocity Map

Explore the full Parkinson’s research intelligence diagram.

Expand Intelligence View →
Full Neurocompute Infographic